ArticleJournal of pharmaceutical analysis2024

YTE-17 inhibits colonic carcinogenesis by resetting antitumor immune response via Wnt5a/JNK mediated metabolic signaling.

Hua Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.